Free Trial

GE HealthCare Technologies (GEHC) Competitors

GE HealthCare Technologies logo
$79.58 +0.33 (+0.42%)
(As of 12:29 PM ET)

GEHC vs. HOLX, BFLY, NNOX, CHEK, AMGN, PFE, SYK, BSX, VRTX, and SNY

Should you be buying GE HealthCare Technologies stock or one of its competitors? The main competitors of GE HealthCare Technologies include Hologic (HOLX), Butterfly Network (BFLY), Nano-X Imaging (NNOX), Check-Cap (CHEK), Amgen (AMGN), Pfizer (PFE), Stryker (SYK), Boston Scientific (BSX), Vertex Pharmaceuticals (VRTX), and Sanofi (SNY).

GE HealthCare Technologies vs.

Hologic (NASDAQ:HOLX) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership.

Hologic has a net margin of 19.59% compared to GE HealthCare Technologies' net margin of 8.56%. GE HealthCare Technologies' return on equity of 25.19% beat Hologic's return on equity.

Company Net Margins Return on Equity Return on Assets
Hologic19.59% 19.79% 11.00%
GE HealthCare Technologies 8.56%25.19%5.93%

Hologic received 854 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 69.61% of users gave Hologic an outperform vote while only 56.76% of users gave GE HealthCare Technologies an outperform vote.

CompanyUnderperformOutperform
HologicOutperform Votes
875
69.61%
Underperform Votes
382
30.39%
GE HealthCare TechnologiesOutperform Votes
21
56.76%
Underperform Votes
16
43.24%

GE HealthCare Technologies has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hologic$4.03B4.07$789.50M$3.3321.70
GE HealthCare Technologies$19.56B1.85$1.57B$3.6421.77

Hologic has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

In the previous week, Hologic had 17 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 29 mentions for Hologic and 12 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.47 beat Hologic's score of 0.65 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hologic
10 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Positive
GE HealthCare Technologies
7 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hologic currently has a consensus target price of $89.50, suggesting a potential upside of 23.86%. GE HealthCare Technologies has a consensus target price of $95.46, suggesting a potential upside of 20.46%. Given Hologic's stronger consensus rating and higher possible upside, research analysts plainly believe Hologic is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hologic
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67
GE HealthCare Technologies
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.64

94.7% of Hologic shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 1.8% of Hologic shares are held by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Hologic beats GE HealthCare Technologies on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEHC vs. The Competition

MetricGE HealthCare TechnologiesX IndustryMedical SectorNASDAQ Exchange
Market Cap$36.21B$12.88B$5.14B$9.31B
Dividend Yield0.15%1.85%4.81%4.06%
P/E Ratio21.7721.74135.1817.53
Price / Sales1.8511.921,235.42140.39
Price / Cash15.6512.7740.6537.95
Price / Book5.052.604.884.92
Net Income$1.57B$273.70M$118.97M$225.78M
7 Day Performance-4.23%-4.03%16.19%-1.58%
1 Month Performance-4.19%3.71%16.02%6.67%
1 Year Performance5.58%38.74%34.95%22.48%

GE HealthCare Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GEHC
GE HealthCare Technologies
4.016 of 5 stars
$79.58
+0.4%
$95.46
+20.0%
+5.7%$36.36B$19.56B21.8651,000Positive News
HOLX
Hologic
4.6876 of 5 stars
$73.14
-0.7%
$89.50
+22.4%
+1.8%$16.60B$4.03B22.147,063Analyst Revision
BFLY
Butterfly Network
0.703 of 5 stars
$3.56
+5.0%
$3.00
-15.7%
+275.7%$758.50M$76.22M-7.37460
NNOX
Nano-X Imaging
2.1278 of 5 stars
$7.34
+6.5%
$12.00
+63.5%
+7.7%$424.10M$10.68M-8.11190
CHEK
Check-Cap
0.4064 of 5 stars
$0.61
-2.5%
N/A-75.4%$3.58MN/A-0.2180Gap Down
AMGN
Amgen
4.6007 of 5 stars
$269.39
-0.5%
$319.68
+18.7%
-3.4%$144.81B$32.53B34.8626,700Analyst Downgrade
PFE
Pfizer
4.9854 of 5 stars
$25.48
-0.4%
$32.15
+26.2%
-0.8%$144.39B$58.50B34.7688,000Dividend Increase
Analyst Forecast
SYK
Stryker
4.9048 of 5 stars
$374.95
+0.1%
$404.35
+7.8%
+27.8%$142.94B$21.97B40.1852,000Positive News
BSX
Boston Scientific
4.5333 of 5 stars
$91.14
+1.1%
$95.52
+4.8%
+62.0%$134.32B$15.91B75.0248,000Analyst Forecast
Short Interest ↑
VRTX
Vertex Pharmaceuticals
4.1985 of 5 stars
$466.88
+0.7%
$505.73
+8.3%
+14.3%$120.24B$9.87B-233.035,400Analyst Forecast
Positive News
SNY
Sanofi
3.5301 of 5 stars
$46.26
-1.2%
$57.50
+24.3%
+2.6%$117.40B$46.61B23.8886,088News Coverage

Related Companies and Tools


This page (NASDAQ:GEHC) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners